Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
13.97
-0.35 (-2.44%)
Apr 9, 2026, 2:45 PM CST
Jiangsu Yahong Meditech Revenue
In the year 2025, Jiangsu Yahong Meditech had annual revenue of 277.12M CNY with 37.49% growth. Jiangsu Yahong Meditech had revenue of 60.71M in the quarter ending December 31, 2025, a decrease of -3.03%.
Revenue
277.12M
Revenue Growth
+37.49%
P/S Ratio
29.07
Revenue / Employee
708.75K
Employees
399
Market Cap
8.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 277.12M | 75.56M | 37.49% |
| Dec 31, 2024 | 201.56M | 187.81M | 1,365.55% |
| Dec 31, 2023 | 13.75M | 13.73M | 52,604.89% |
| Dec 31, 2022 | 26.10K | 21.52K | 470.51% |
| Dec 31, 2021 | 4.57K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.07B |
| China Animal Husbandry Industry | 6.28B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Tianjin Tianyao Pharmaceuticals | 2.87B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Jiuzhitang | 2.23B |